Abstract
A lectin from Vatairea macrocarpa (Vmac) seeds was investigated in a model of paw edema in rats and the possible involvement of leukocytes. Vmac (200 and 400μg / paw, s.c.) induced a significant time- and dose-dependent paw edema, with leukocyte infiltration, which was drastically reduced in leukopaenic animals. These data suggest a pro-inflammatory effect for this lectin that is dependent on the presence of leukocytes.
Keywords: paw edema,, leukocyte infiltration,, Vatairea macrocarpa lectin.
Protein & Peptide Letters
Title: Vatairea Macrocarpa Lectin Induces Paw Edema With Leukocyte Infiltration.
Volume: 11 Issue: 2
Author(s): Nylane M.N. Alencar, Ana M.S. Assreuy, David N. Criddle, Emmanuel P. Souza, Pedro M.G. Soares, Alexandre Havt, Karoline S. Aragao, Daniel P. Bezerra, Ronaldo A. Ribeiro and Benildo S. Cavada
Affiliation:
Keywords: paw edema,, leukocyte infiltration,, Vatairea macrocarpa lectin.
Abstract: A lectin from Vatairea macrocarpa (Vmac) seeds was investigated in a model of paw edema in rats and the possible involvement of leukocytes. Vmac (200 and 400μg / paw, s.c.) induced a significant time- and dose-dependent paw edema, with leukocyte infiltration, which was drastically reduced in leukopaenic animals. These data suggest a pro-inflammatory effect for this lectin that is dependent on the presence of leukocytes.
Export Options
About this article
Cite this article as:
Alencar M.N. Nylane, Assreuy M.S. Ana, Criddle N. David, Souza P. Emmanuel, Soares M.G. Pedro, Havt Alexandre, Aragao S. Karoline, Bezerra P. Daniel, Ribeiro A. Ronaldo and Cavada S. Benildo, Vatairea Macrocarpa Lectin Induces Paw Edema With Leukocyte Infiltration., Protein & Peptide Letters 2004; 11 (2) . https://dx.doi.org/10.2174/0929866043478284
DOI https://dx.doi.org/10.2174/0929866043478284 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Dietary Polyphenols in the Management of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients
Current Pharmaceutical Design White Matter Neuroprotection in Preterm Infants
Current Pediatric Reviews Complement Components, C3 and C4, and the Metabolic Syndrome
Current Diabetes Reviews Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis
Current Gene Therapy Improving Brain Drug Targeting Through Exploitation of The Nose-to- Brain Route: A Physiological and Pharmacokinetic Perspective
Current Drug Delivery Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity
Current Drug Targets Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets CD164 as a Basophil Activation Marker
Current Pharmaceutical Design Synthesis and Anticancer Activity Evaluation of Some Benzothiazole-Piperazine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Properties of Thalidomide and its Analogues
Recent Patents on Inflammation & Allergy Drug Discovery Drug Targets in Infections with Other Emerging Viruses: Influenza Viruses, Metapneumovirus and Hantaviruses
Infectious Disorders - Drug Targets Editorial: Uveitis: Pathology, Molecular Mechanisms and Therapy
Current Molecular Medicine Aminophosphonic Acids of Potential Medical Importance
Current Medicinal Chemistry - Anti-Cancer Agents Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
Current Cancer Drug Targets Antioxidant to Treat Osteoarthritis: Dream or Reality?
Current Drug Targets The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Current Drug Targets for the Critically Ill COPD Patient (Guest Editors: Demosthenes Makris and Epaminondas Zakynthinos)]
Current Drug Targets Integrating Pathophysiology in Migraine: Role of the Gut Microbiome and Melatonin
Current Pharmaceutical Design